default author photo

Ben Gombe

MRC/UVRI & LSHTM Uganda Research Unit

SCHOLARLY PAPERS

2

DOWNLOADS

300

TOTAL CITATIONS

3

Scholarly Papers (2)

1.

Safety and Broad Immunogenicity of HIVconsvX Conserved Mosaic Candidate T-Cell Vaccines Vectored by ChAdOx1 and MVA in HIV-CORE 006: A Double-Blind, Randomized, Placebo-Controlled Phase 1 Trial in Healthy Adults Living Without HIV-1 in Eastern and Southern Africa

Number of pages: 24 Posted: 26 Mar 2024
Center for Family Health Research Zambia (CFHRZ), Government of Uganda - Uganda Virus Research Institute (UVRI), University of Nairobi, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, IAVI, University of Oxford, IAVI, University of Oxford, MRC/UVRI & LSHTM Uganda Research Unit, University of Oxford, University of Nairobi, Center for Family Health Research Zambia (CFHRZ), IAVI, IAVI, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, University of Oxford, IAVI, Imperial College London - IAVI Human Immunology Laboratory, London School of Hygiene & Tropical Medicine - Uganda Research Unit, IAVI, University of Oxford, MRC/UVRI & LSHTM Uganda Research Unit, affiliation not provided to SSRN, Imperial College London - IAVI Human Immunology Laboratory, Center for Family Health Research Zambia (CFHRZ), Center for Family Health Research Zambia (CFHRZ), affiliation not provided to SSRN, Center for Family Health Research Zambia (CFHRZ), MRC/UVRI & LSHTM Uganda Research Unit, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, International AIDS Vaccine Initiative, Imperial College London - IAVI Human Immunology Laboratory, Center for Family Health Research Zambia (CFHRZ), University of Nairobi, University of Nairobi, IAVI, Center for Family Health Research Zambia (CFHRZ), Center for Family Health Research Zambia (CFHRZ), London School of Hygiene & Tropical Medicine - Uganda Research Unit, University of Nairobi, MRC/UVRI & LSHTM Uganda Research Unit, Oxus Technologies Limited, University of Nairobi, Center for Family Health Research Zambia (CFHRZ), University of Nairobi, Center for Family Health Research Zambia (CFHRZ), Center for Family Health Research Zambia (CFHRZ), University of Nairobi, MRC/UVRI & LSHTM Uganda Research Unit, MRC/UVRI & LSHTM Uganda Research Unit, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, IAVI, University of Nairobi, University of Nairobi, UVRI-IAVI HIV Vaccine Program, University of Nairobi, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, IAVI, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, University of California, San Francisco (UCSF) - Department of Medicine, IAVI, University of Nairobi, London School of Hygiene & Tropical Medicine - Uganda Research Unit, University of Oxford, Imperial College London - IAVI Human Immunology Laboratory, University of Oxford - Oxford Vaccine Group, International AIDS Vaccine Initiative, Imperial College London - Department of Infectious Disease, University of Nairobi, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Center for Family Health Research Zambia (CFHRZ), IAVI, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme and University of Oxford - The Jenner Institute
Downloads 186 (409,459)

Abstract:

Loading...

T cells, T-cell vaccine, HIV vaccine: conserved regions, phase I trial, HIVconsvX, ChAdOx1, MVA, vaccine safety, vaccine immunogenicity, clinical trial, virus inhibition assay, HIV-1

2.

Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals

Number of pages: 60 Posted: 19 Feb 2025
London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Imperial College London - Department of Infectious Disease, Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, MRC/UVRI & LSHTM Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease and London School of Hygiene & Tropical Medicine - Uganda Research Unit
Downloads 114 (630,858)
Citation 3

Abstract:

Loading...

Self-amplifying RNA (saRNA) vaccine, SARS-CoV-2 immunogenicity, COVID-19 Vaccination in Africa, Neutralising antibody responses, Spike-specific IgG antibodies, Vaccine safety and reactogenicity, Seronegative vs. seropositive immune response